Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
TechCrunch
Read Full Article at TechCrunch →Ad Slot — In-Article (728x90)
Biotech company Imperagen announced on Thursday a £5 million ($6. 7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
This is a summary. For the full story, read the original article at TechCrunch.
Original source: TechCrunch